Tuesday, August 16, 2005

Gabapentin for the Symptomatic Treatment of Chronic Neuropathic Pain in Patients with Late-Stage Lyme Borreliosis: A Pilot Study

Department of Dermatology and Allergy Biederstein, Technical University of Munich, Munich, Germany
Background: Chronic neuropathic pain occurs in 10-15% of patients with neuroborreliosis and is difficult to treat. Objective: We evaluated the effect of gabapentin monotherapy on residual pain in patients with neuroborreliosis after intravenous ceftriaxone treatment.
full abstract